Eperisone (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Eperisone" in Italian language version.

refsWebsite

Global rank Italian rank

21nih.gov

4^th place

9^th place

5doi.org

2^nd place

7^th place

2jst.go.jp

1,903^rd place

3,782^nd place

1wkhealth.com

low place

7,876^th place

1drugliterature.blogspot.it

low place

1archive.org

6^th place

8^th place

1aspetjournals.org

6,663^rd place

5,217^th place

1curehunter.com

low place

1jpgmonline.com

low place

1prous.com

low place

1minervamedica.it

low place

9,617^th place

1wiley.com

222^nd place

243^rd place

1web.archive.org

1^st place

1oadoi.org

799^th place

22^nd place

archive.org

Ishizuki M, Yanagisawa M, Antinociceptive effects of tizanidine, diazepam and eperisone in isolated spinal cord-tail preparations of newborn rat, in Pain, vol. 48, n. 1, gennaio 1992, pp. 101–6, PMID 1482424.

aspetjournals.org

jpet.aspetjournals.org

Fujioka M, Kuriyama H, Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery, in The Journal of Pharmacology and Experimental Therapeutics, vol. 235, n. 3, dicembre 1985, pp. 757–63, PMID 3935775. URL consultato il 14 dicembre 2014.

curehunter.com

http://www.curehunter.com/public/kerywordSummaryC030848--4--ethly-2-methly-3-piperidino-propiophenone.do^{[collegamento interrotto]}

doi.org

dx.doi.org

Sakai Y, Matsuyama Y, Nakamura H, Katayama Y, Imagama S, Ito Z, Okamoto A, Ishiguro N, The effect of muscle relaxant on the paraspinal muscle blood flow: a randomized controlled trial in patients with chronic low back pain ^{[collegamento interrotto]}, in Spine, vol. 33, n. 6, marzo 2008, pp. 581–7, DOI:10.1097/BRS.0b013e318166e051, PMID 18344850. URL consultato il 14 dicembre 2014.
Melilli B, Piazza C, Vitale DC, Marano MR, Pecori A, Mattana P, Volsi VL, Iuculano C, Cardì F, Drago F, Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry, in European Journal of Drug Metabolism and Pharmacokinetics, vol. 36, n. 2, giugno 2011, pp. 71–8, DOI:10.1007/s13318-011-0034-0, PMID 21448778. URL consultato il 14 dicembre 2014.
Chandanwale AS, Chopra A, Goregaonkar A, Medhi B, Shah V, Gaikwad S, Langade DG, Maroli S, Mehta SC, Naikwadi A, Pawar DR, Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial, in Journal of Postgraduate Medicine, vol. 57, n. 4, 2011, pp. 278–85, DOI:10.4103/0022-3859.90076, PMID 22120855. URL consultato il 14 dicembre 2014.
Sartini S, Guerra L, Open experience with a new myorelaxant agent for low back pain, in Advances in Therapy, vol. 25, n. 10, ottobre 2008, pp. 1010–8, DOI:10.1007/s12325-008-0108-9, PMID 18836866. URL consultato il 14 dicembre 2014.
van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM, Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration, in Spine, vol. 28, n. 17, settembre 2003, pp. 1978–92, DOI:10.1097/01.BRS.0000090503.38830.AD, PMID 12973146. URL consultato il 14 dicembre 2014.

drugliterature.blogspot.it

Drug literature: Eperosone Drug Literature All About Drugs^{[collegamento interrotto]}

jpgmonline.com

Chandanwale AS, Chopra A, Goregaonkar A, Medhi B, Shah V, Gaikwad S, Langade DG, Maroli S, Mehta SC, Naikwadi A, Pawar DR, Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial, in Journal of Postgraduate Medicine, vol. 57, n. 4, 2011, pp. 278–85, DOI:10.4103/0022-3859.90076, PMID 22120855. URL consultato il 14 dicembre 2014.

jst.go.jp

joi.jlc.jst.go.jp

Nakajima Y, Wada N, Effects of eperisone-HCl on the stretch reflex in anesthetized cats, in Japanese Journal of Pharmacology, vol. 51, n. 4, dicembre 1989, pp. 572–6, PMID 2615051. URL consultato il 14 dicembre 2014.
Inoue S, Bian K, Okamura T, Okunishi H, Toda N, Mechanisms of action of eperisone on isolated dog saphenous arteries and veins, in Japanese Journal of Pharmacology, vol. 50, n. 3, luglio 1989, pp. 271–82, PMID 2761129. URL consultato il 14 dicembre 2014.

minervamedica.it

Rossi M, Ianigro G, Liberatoscioli G, Di Castelnuovo A, Grimani V, Garofano A, Camposarcone N, Nardi LF, Eperisone versus tizanidine for treatment of chronic low back pain, in Minerva Medica, vol. 103, n. 3, giugno 2012, pp. 143–9, PMID 22653094. URL consultato il 14 dicembre 2014.

nih.gov

ncbi.nlm.nih.gov

Iwase S, Mano T, Saito M, Ishida G, Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans, in Functional Neurology, vol. 7, n. 6, 1992, pp. 459–70, PMID 1338431.
Sakai Y, Matsuyama Y, Nakamura H, Katayama Y, Imagama S, Ito Z, Okamoto A, Ishiguro N, The effect of muscle relaxant on the paraspinal muscle blood flow: a randomized controlled trial in patients with chronic low back pain ^{[collegamento interrotto]}, in Spine, vol. 33, n. 6, marzo 2008, pp. 581–7, DOI:10.1097/BRS.0b013e318166e051, PMID 18344850. URL consultato il 14 dicembre 2014.
Beltrame A, Grangiè S, Guerra L, Clinical experience with eperisone in the treatment of acute low back pain, in Minerva Medica, vol. 99, n. 4, agosto 2008, pp. 347–52, PMID 18663343.
Morikawa K, Oshita M, Yamazaki M, Ohara N, Mizutani F, Kato H, Ito Y, Kontani H, Koshiura R, Pharmacological studies of the new centrally acting muscle relaxant 4'-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride, in Arzneimittel-Forschung, vol. 37, n. 3, marzo 1987, pp. 331–6, PMID 3593447.
Ishizuki M, Yanagisawa M, Antinociceptive effects of tizanidine, diazepam and eperisone in isolated spinal cord-tail preparations of newborn rat, in Pain, vol. 48, n. 1, gennaio 1992, pp. 101–6, PMID 1482424.
Nakajima Y, Wada N, Effects of eperisone-HCl on the stretch reflex in anesthetized cats, in Japanese Journal of Pharmacology, vol. 51, n. 4, dicembre 1989, pp. 572–6, PMID 2615051. URL consultato il 14 dicembre 2014.
Novales-Li P, Sun XP, Takeuchi H, Suppression of calcium current in a snail neurone by eperisone and its analogues, in European Journal of Pharmacology, vol. 168, n. 3, settembre 1989, pp. 299–305, PMID 2555204.
Inoue S, Bian K, Okamura T, Okunishi H, Toda N, Mechanisms of action of eperisone on isolated dog saphenous arteries and veins, in Japanese Journal of Pharmacology, vol. 50, n. 3, luglio 1989, pp. 271–82, PMID 2761129. URL consultato il 14 dicembre 2014.
Fujioka M, Kuriyama H, Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery, in The Journal of Pharmacology and Experimental Therapeutics, vol. 235, n. 3, dicembre 1985, pp. 757–63, PMID 3935775. URL consultato il 14 dicembre 2014.
Melilli B, Piazza C, Vitale DC, Marano MR, Pecori A, Mattana P, Volsi VL, Iuculano C, Cardì F, Drago F, Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry, in European Journal of Drug Metabolism and Pharmacokinetics, vol. 36, n. 2, giugno 2011, pp. 71–8, DOI:10.1007/s13318-011-0034-0, PMID 21448778. URL consultato il 14 dicembre 2014.
Mihara K, Matsumura M, Yoshioka E, Hanada K, Nakasa H, Ohmori S, Kitada M, Ogata H, Intestinal first-pass metabolism of eperisone in the rat, in Pharmaceutical Research, vol. 18, n. 8, agosto 2001, pp. 1131–7, PMID 11587484.
Bresolin N, Zucca C, Pecori A, Efficacy and tolerability of eperisone in patients with spastic palsy: a cross-over, placebo-controlled dose-ranging trial, in European Review for Medical and Pharmacological Sciences, vol. 13, n. 5, 2009, pp. 365–70, PMID 19961042.
Tariq M, Akhtar N, Ali M, Rao S, Badshah M, Irshad M, Eperisone compared to physiotherapy on muscular tone of stroke patients: a prospective randomized open study, in JPMA. the Journal of the Pakistan Medical Association, vol. 55, n. 5, maggio 2005, pp. 202–4, PMID 15960286.
Chandanwale AS, Chopra A, Goregaonkar A, Medhi B, Shah V, Gaikwad S, Langade DG, Maroli S, Mehta SC, Naikwadi A, Pawar DR, Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial, in Journal of Postgraduate Medicine, vol. 57, n. 4, 2011, pp. 278–85, DOI:10.4103/0022-3859.90076, PMID 22120855. URL consultato il 14 dicembre 2014.
Cabitza P, Randelli P, Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study, in European Review for Medical and Pharmacological Sciences, vol. 12, n. 4, 2008, pp. 229–35, PMID 18727454.
Bose K, The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial, in Methods and Findings in Experimental and Clinical Pharmacology, vol. 21, n. 3, aprile 1999, pp. 209–13, PMID 10389124. URL consultato il 14 dicembre 2014.
Sartini S, Guerra L, Open experience with a new myorelaxant agent for low back pain, in Advances in Therapy, vol. 25, n. 10, ottobre 2008, pp. 1010–8, DOI:10.1007/s12325-008-0108-9, PMID 18836866. URL consultato il 14 dicembre 2014.
Rossi M, Ianigro G, Liberatoscioli G, Di Castelnuovo A, Grimani V, Garofano A, Camposarcone N, Nardi LF, Eperisone versus tizanidine for treatment of chronic low back pain, in Minerva Medica, vol. 103, n. 3, giugno 2012, pp. 143–9, PMID 22653094. URL consultato il 14 dicembre 2014.
Choonhakarn C, Non-pigmenting fixed drug eruption: a new case due to eperisone hydrochloride, in The British Journal of Dermatology, vol. 144, n. 6, giugno 2001, pp. 1288–9, PMID 11422074. URL consultato il 14 dicembre 2014.
Ueno T, Kawana S, [A case of eperisone hydrochloride (myonal)--induced drug eruption leading to erythema and angioedema], in Arerugī = [Allergy], vol. 56, n. 7, luglio 2007, pp. 709–13, PMID 17671415. URL consultato il 14 dicembre 2014 (archiviato dall'url originale il 19 dicembre 2014).
van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM, Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration, in Spine, vol. 28, n. 17, settembre 2003, pp. 1978–92, DOI:10.1097/01.BRS.0000090503.38830.AD, PMID 12973146. URL consultato il 14 dicembre 2014.

oadoi.org

van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM, Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration, in Spine, vol. 28, n. 17, settembre 2003, pp. 1978–92, DOI:10.1097/01.BRS.0000090503.38830.AD, PMID 12973146. URL consultato il 14 dicembre 2014.

prous.com

journals.prous.com

Bose K, The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial, in Methods and Findings in Experimental and Clinical Pharmacology, vol. 21, n. 3, aprile 1999, pp. 209–13, PMID 10389124. URL consultato il 14 dicembre 2014.

web.archive.org

Ueno T, Kawana S, [A case of eperisone hydrochloride (myonal)--induced drug eruption leading to erythema and angioedema], in Arerugī = [Allergy], vol. 56, n. 7, luglio 2007, pp. 709–13, PMID 17671415. URL consultato il 14 dicembre 2014 (archiviato dall'url originale il 19 dicembre 2014).

wiley.com

onlinelibrary.wiley.com

Choonhakarn C, Non-pigmenting fixed drug eruption: a new case due to eperisone hydrochloride, in The British Journal of Dermatology, vol. 144, n. 6, giugno 2001, pp. 1288–9, PMID 11422074. URL consultato il 14 dicembre 2014.

wkhealth.com

meta.wkhealth.com

Sakai Y, Matsuyama Y, Nakamura H, Katayama Y, Imagama S, Ito Z, Okamoto A, Ishiguro N, The effect of muscle relaxant on the paraspinal muscle blood flow: a randomized controlled trial in patients with chronic low back pain ^{[collegamento interrotto]}, in Spine, vol. 33, n. 6, marzo 2008, pp. 581–7, DOI:10.1097/BRS.0b013e318166e051, PMID 18344850. URL consultato il 14 dicembre 2014.